Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 12(10): e0187192, 2017.
Article in English | MEDLINE | ID: mdl-29077773

ABSTRACT

Nasal mucosa and olfactory bulb are separated by the cribriform plate which is perforated by olfactory nerves. We have previously demonstrated that the cribriform plate is permissive for T cells and monocytes and that viruses can enter the bulb upon intranasal injection by axonal transportation. Therefore, we hypothesized that nasal mucosa and olfactory bulb are equipped to deal with constant infectious threats. To detect genes involved in this process, we compared gene expression in nasal mucosa and bulb of mice kept under specific pathogen free (SPF) conditions to gene expression of mice kept on non-SPF conditions using RNA deep sequencing. We found massive alterations in the expression of immune-related genes of the nasal mucosa, while the bulb did not respond immunologically. The absence of induction of immune-related genes in the olfactory bulb suggests effective defence mechanisms hindering entrance of environmental pathogens beyond the outer arachnoid layer. The genes detected in this study may include candidates conferring susceptibility to meningitis.


Subject(s)
Nasal Mucosa/immunology , Olfactory Bulb/immunology , Olfactory Mucosa/immunology , Animals , Mice , Sequence Analysis, RNA
2.
Arterioscler Thromb Vasc Biol ; 34(12): 2658-68, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25341795

ABSTRACT

OBJECTIVE: Interleukin (IL)-17A is regarded as an important cytokine to drive psoriasis, an inflammatory skin disease marked by increased cardiovascular mortality. We aimed to test the hypothesis that overproduction of IL-17A in the skin leading to dermal inflammation may systemically cause vascular dysfunction in psoriasis-like skin disease. APPROACH AND RESULTS: Conditional overexpression of IL-17A in keratinocytes caused severe psoriasis-like skin inflammation in mice (K14-IL-17A(ind/+) mice), associated with increased reactive oxygen species formation and circulating CD11b(+) inflammatory leukocytes in blood, with endothelial dysfunction, increased systolic blood pressure, left ventricular hypertrophy, and reduced survival compared with controls. In K14-IL-17A(ind/+) mice, immunohistochemistry and flow cytometry revealed increased vascular production of the nitric oxide/superoxide reaction product peroxynitrite and infiltration of the vasculature with myeloperoxidase(+)CD11b(+)GR1(+)F4/80(-) cells accompanied by increased expression of the inducible nitric oxide synthase and the nicotinamide dinucleotide phosphate (NADPH) oxidase, nox2. Neutrophil depletion by anti-GR-1 antibody injections reduced oxidative stress in blood and vessels. Neutralization of tumor necrosis factor-α and IL-6 (both downstream of IL-17A) reduced skin lesions, attenuated oxidative stress in heart and blood, and partially improved endothelial dysfunction in K14-IL-17A(ind/+) mice. CONCLUSIONS: Dermal overexpression of IL-17A induces systemic endothelial dysfunction, vascular oxidative stress, arterial hypertension, and increases mortality mainly driven by myeloperoxidase(+)CD11b(+)GR1(+)F4/80(-) inflammatory cells. Depletion of the GR-1(+) immune cells or neutralization of IL-17A downstream cytokines by biologicals attenuates the vascular phenotype in K14-IL-17A(ind/+) mice.


Subject(s)
Interleukin-17/physiology , Psoriasis/etiology , Psoriasis/physiopathology , Adult , Aged , Aged, 80 and over , Animals , Aorta/pathology , Cardiovascular Diseases/etiology , Case-Control Studies , Disease Models, Animal , Endothelium, Vascular/immunology , Endothelium, Vascular/physiopathology , Female , Humans , Hypertension/etiology , Hypertension/immunology , Hypertension/physiopathology , Interleukin-17/genetics , Interleukin-6/antagonists & inhibitors , Interleukin-6/physiology , Keratinocytes/immunology , Keratinocytes/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Middle Aged , Myocytes, Cardiac/pathology , Neutrophils/pathology , Neutrophils/physiology , Nitric Oxide/metabolism , Psoriasis/complications , Reactive Oxygen Species/metabolism , Risk Factors , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/physiology , Up-Regulation , Vasculitis/etiology , Vasculitis/immunology , Vasculitis/physiopathology
3.
J Invest Dermatol ; 134(3): 728-735, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24067382

ABSTRACT

The lack of a generally accepted animal model for human psoriasis has hindered progress with respect to understanding the pathogenesis of the disease. Here we present a model in which transgenic IL-17A expression is targeted to the skin in mice, achievable after crossing our IL-17A(ind) allele to the K14-Cre strain. K14-IL-17A(ind/+) mice invariably develop an overt skin inflammation bearing many hallmark characteristics of human psoriasis including dermal infiltration of effector T cells, formation of neutrophil microabscesses, and hyperkeratosis. IL-17A expression in the skin results in upregulated granulopoiesis and migration of IL-6R-expressing neutrophils into the skin. Neutralization of IL-6 signaling efficiently reduces the observed pathogenesis in skin of IL-17A-overexpressing mice, with marked reductions in epidermal neutrophil abscess formation and epidermal thickening. Thus, IL-6 functions downstream of IL-17A to exacerbate neutrophil microabscess development in psoriasiform lesions.


Subject(s)
Abscess/immunology , Interleukin-17/immunology , Interleukin-6/immunology , Neutrophils/immunology , Psoriasis/immunology , Abscess/drug therapy , Abscess/pathology , Animals , Disease Models, Animal , Epidermis/immunology , Epidermis/metabolism , Epidermis/pathology , Gene Expression/immunology , Granulocytes/immunology , Granulocytes/pathology , Interleukin-17/genetics , Interleukin-17/metabolism , Interleukin-6/metabolism , Interleukin-6/pharmacology , Macrophages/immunology , Macrophages/pathology , Mice , Mice, Knockout , Neutrophils/metabolism , Psoriasis/drug therapy , Psoriasis/pathology , Receptors, Interleukin-6/genetics , Receptors, Interleukin-6/immunology , Signal Transduction/drug effects , Signal Transduction/immunology , T-Lymphocytes/immunology , T-Lymphocytes/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...